Experience with pharmacologic leeching with bivalirudin for adjunct treatment of venous congestion of head and neck reconstructive flaps
Harun A, Kruer RM, Lee A, Boahene K, Byrne PJ, Richmon JD (2018) · Microsurgery · n=10
Studienprofil
- Design
- single-institution retrospective comparative cohort study of patients receiving intradermal bivalirudin injections (pharmacologic leeching) as adjunct treatment for venous congestion of head and neck reconstructive flaps at Johns Hopkins University School of Medicine, September 2012 through September 2015
- Stichprobengröße (n)
- 10
- Intervention
- Variable number of intradermal injections of bivalirudin (a synthetic 20-amino-acid analog of leech hirudin) directly into the venous-congested flap, followed by a small skin incision to allow extended passive bleeding — described by the authors as 'pharmacologic leeching' designed to mimic the physiologic effect of medicinal leech therapy
- Komparator
- Within-cohort descriptive comparison to historical leech therapy outcomes; bivalirudin used as adjunct (n=6) or solo (n=4); 2 patients underwent alternate therapy after the first bivalirudin injection
- Primärer Endpunkt
- Improvement of flap congestion and reduction of partial/complete flap necrosis following bivalirudin administration
- Primäres Ergebnis
- Among 10 patients with free flap reconstruction of various head and neck defects (4 ALT, 2 pectoralis major, 2 fibula osseocutaneous, 1 supraclavicular, 1 radial forearm), 8 patients had assessable outcomes; among these 8, 4 developed partial necrosis and 1 developed complete necrosis requiring reconstruction; 2 patients required blood transfusions during treatment; authors concluded bivalirudin is feasible/safe as adjunct therapy for flap congestion but efficacy versus standard medicinal leech therapy requires further work
- Follow-up-Dauer
- duration of hospitalization plus institutional postoperative monitoring
- PMID
- 29344982
Wichtigste Ergebnisse
- First published US clinical experience with intradermal bivalirudin as a 'pharmacologic leech' alternative
- Johns Hopkins protocol used intradermal injection plus skin incision to mimic the prolonged passive bleeding effect of leeches
- Safety profile feasible but efficacy outcomes mixed (5 of 8 evaluable flaps developed partial or complete necrosis)
- Two patients required blood transfusions — bleeding risk is not eliminated by switching from whole leech to synthetic analog
- Authors framed bivalirudin as a leech-alternative addressing infection risk (no Aeromonas), psychological aversion, and leech migration risk
Einschränkungen
- Very small sample (n=10) - exploratory pilot only
- Retrospective single-institution design — outcome adjudication and indication selection biased
- Heterogeneous flap types pooled — efficacy may vary by flap and anatomical site
- No randomized comparator to medicinal leech therapy
- Bivalirudin is not FDA-cleared for this off-label intradermal use — investigational protocol only
Klinische Implikationen
Harun 2018 is the most cited US clinical attempt to develop a 'pharmacologic leech' alternative using intradermal bivalirudin. For US clinicians, the trial documents that direct thrombin inhibitor injection is feasible and may avoid some leech-specific harms (Aeromonas infection, psychological aversion, leech migration) but does not demonstrate equivalent salvage efficacy to medicinal leech therapy. The pilot is hypothesis-generating; pending randomized comparison, the K040187-cleared medicinal leech remains the standard of care for venous congestion of microsurgical flaps. The trial supports continued translational research into leech-derived pharmacologic alternatives but does not change current clinical practice.
Verwandte Studien
Medicinal leech therapy in venous congestion of microsurgical flaps: a randomized comparison with heparin pinprick scarification
Merlino G, Carbone S, Servillo G, Marletta DA (2020)
Adjunctive medicinal leech therapy for venous congestion in free flaps: a German multicenter randomized trial
Lehnhardt M, Daigeler A, Behr B, Schmidt SV, Wallner C (2021)
Medicinal leeches and the microsurgeon: a four-year study, clinical series and risk benefit review
Whitaker IS, Josty IC, Hawkins S, Azzopardi E, Naderi N, Graf J, Damaris L, Lineaweaver WC, Kon M (2011)
Medicinal leeches for surgically uncorrectable venous congestion after free flap breast reconstruction
Pannucci CJ, Nelson JA, Chung CU, Fischer JP, Kanchwala SK, Kovach SJ, Serletti JM, Wu LC (2014)